Literature DB >> 6302179

Intracerebral inoculation of newborn and adult mice with thymidine kinase-deficient mutants of herpes simplex virus type 1.

R B Tenser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6302179     DOI： 10.1093/infdis/147.5.956

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

Review 1.  Resistance of herpesviruses to antiviral drugs.

Authors:  P A Chatis; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

2.  Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin.

Authors:  Graciela Andrei; Jan Balzarini; Pierre Fiten; Erik De Clercq; Ghislain Opdenakker; Robert Snoeck
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Drug combinations for treatment of mice infected with acyclovir-resistant herpes simplex virus.

Authors:  R F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

4.  Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS.

Authors:  R L Thompson; M L Cook; G B Devi-Rao; E K Wagner; J G Stevens
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

5.  Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.

Authors:  W D Hunter; R L Martuza; F Feigenbaum; T Todo; T Mineta; T Yazaki; M Toda; J T Newsome; R C Platenberg; H J Manz; S D Rabkin
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Characterization of a varicella-zoster virus variant with altered thymidine kinase activity.

Authors:  S Shigeta; S Mori; T Yokota; K Konno; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

7.  Extreme susceptibility of African naked mole rats (Heterocephalus glaber) to experimental infection with herpes simplex virus type 1.

Authors:  James Artwohl; Susan Ball-Kell; Tibor Valyi-Nagy; Steven P Wilson; Ying Lu; Thomas J Park
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.